Company Name Visterra
Mailing Address One Kendall Square Cambridge, MA 02139
Company Description Visterra, Inc. is dedicated to the discovery and development of innovative products for the prevention, treatment and diagnosis of infectious diseases. The Company focuses on technologies that can interrogate how pathogens interact with human cells, a critical first step in the disease process. The company’s lead programs are focused on seasonal and pandemic influenza.
Proceeds Purposes Proceeds will be used to further develop and validate Visterra’s technology platform and advance its proprietary infectious disease product pipeline. The company’s lead product candidate, VIS410, is a broad spectrum antibody for the prevention and treatment of both seasonal and pandemic influenza.